Circulating tumor cells in metastatic colorectal cancer: Do we need an alternative cutoff?

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 8, 2013, Pages 1411-1416

  Gazzaniga, P ^a   Raimondi, C ^a   Gradilone, A ^a   Biondi Zoccai, G ^b   Nicolazzo, C ^a   Gandini, O ^a   Longo, F ^a   Tomao, S ^b   Lo Russo, G ^b   Seminara, P ^a   Vincenzi, B ^c   Chimenti, I ^b   Cristofanilli, M ^d   Frati, L ^b   Cortesi, E ^e  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CellSearch; Circulating tumor cells; Colorectal cancer; Cutoff

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CELL COUNT; CIRCULATING TUMOR CELL; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OVERALL SURVIVAL; PATIENT ASSESSMENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 84880919497     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1450-0     Document Type: Article

References (14)

1. Alix-Panabières C, Pantel K (2013) Circulating tumor cells: liquid biopsy of cancer. Clin Chem 59(1):110-118. doi: 10.1373/clinchem.2012.194258
2. Allard WJ, Matera J, Miller MC et al (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897-6904. doi: 10.1158/1078-0432.CCR-04-0378
3. Barbazán J, Alonso-Alconada L, Muinelo-Romay L et al (2012) Molecular characterization of circulating tumor cells in human metastatic colorectal cancer. PLoS ONE 7(7):e40476. doi: 10.1371/journal.pone.0040476
4. Bidard FC, Ferrand FR, Huguet F et al (2012) Disseminated and circulating tumor cells in gastrointestinal oncology. Crit Rev Oncol Hematol 82(2):103-115. doi: 10.1016/j.critrevonc.2011.05.008
5. Cohen SJ, Punt CJ, Iannotti N et al (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213-3221. doi: 10.1200/JCO.2007.15.8923
6. Cohen SJ, Punt CJ, Iannotti N et al (2009) Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20(7):1223-1229. doi: 10.1093/annonc/mdn786
7. Cristofanilli M, Budd GT, Ellis MJ et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781-791. doi: 10.1056/NEJMoa040766
8. de Bono JS, Scher HI, Montgomery RB et al (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19):6302-6309. doi: 10.1158/1078-0432.CCR- 08-0872
9. De Mattos-Arruda L, Dienstmann R, Tabernero J (2011) Development of molecular biomarkers in individualized treatment of colorectal cancer. Clin Colorectal Cancer 10(4):279-289. doi: 10.1158/1078-0432.CCR-08-0872
10. Gazzaniga P, Raimondi C, Gradilone A et al (2011) Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. Ann Oncol 22(8):1929-1930. doi: 10.1093/annonc/mdr292
11. Parkinson DR, Dracopoli N, Petty BG et al (2012) Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 10:138. doi: 10.1186/1479-5876-10-138
12. Sastre J, Maestro ML, Gómez-España A et al (2012) Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist 17(7):947-955. doi: 10.1634/theoncologist.2012-0048
13. Tol J, Koopman M, Miller MC et al (2010) Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 21(5):1006-1012. doi: 10.1093/annonc/mdp463
14. Troiani T, Martinelli E, Morgillo F et al (2013) Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab? Ther Adv Med Oncol 5(1):51-72. doi: 10.1177/1758834012462462